[Comparative Analysis of MPTP Neurotoxicity in Mice with a Constitutive Knockout of the α-Synuclein Gene].


Journal

Molekuliarnaia biologiia
ISSN: 0026-8984
Titre abrégé: Mol Biol (Mosk)
Pays: Russia (Federation)
ID NLM: 0105454

Informations de publication

Date de publication:
Historique:
received: 08 07 2020
accepted: 30 08 2020
entrez: 10 2 2021
pubmed: 11 2 2021
medline: 13 2 2021
Statut: ppublish

Résumé

Aggregated forms of α-synuclein are core components of pathohistological inclusions known as Lewy bodies in substantia nigra (SN) neurons of patients with Parkinson's disease (PD). The role of α-synuclein in selective loss of SN dopaminergic neurons (DNs) in PD is studied in mice knocked out in the α-synuclein gene. The new mouse strain delta flox KO with a constitutive knockout of the α-synuclein gene models the end point of in vivo deletion of the α-synuclein gene in mice with a conditional knockout and has no foreign sequence in the modified genomic locus, thus differing from all other α-synuclein knockout mouse strains. The effect of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), which is used to model PD, was compared between delta flox KO mice and mice of the well-known α-synuclein knockout strain AbKO. Subchronic MPTP administration, which models early PD, was found to reduce the dopamine content and to change the ratio of dopamine metabolites in the striatum to the same levels in delta flox KO, АbKO, and wild-type mice. Overt locomotor defects were not observed after MPTP treatment, but gait testing in a CatWalk XT (Noldus) system revealed identical gait deviations in mice of the two strains and control wild-type mice. Based on the findings, a similar mechanism of neurotoxic damage to DNs was assumed for delta flox KO and AbKO mice.

Identifiants

pubmed: 33566034
doi: 10.31857/S0026898421010031
doi:

Substances chimiques

alpha-Synuclein 0
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine 9P21XSP91P

Types de publication

Journal Article

Langues

rus

Sous-ensembles de citation

IM

Pagination

152-163

Auteurs

K D Chaprov (KD)

Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Moscow oblast, 142432 Russia.
chaprov@ipac.ac.ru.

E V Teterina (EV)

Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Moscow oblast, 142432 Russia.

A Yu Roman (AY)

Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Moscow oblast, 142432 Russia.

T A Ivanova (TA)

Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Moscow oblast, 142432 Russia.

V V Goloborshcheva (VV)

Institute of General Pathology and Pathophysiology, Moscow, 125315 Russia.

V G Kucheryanu (VG)

Institute of General Pathology and Pathophysiology, Moscow, 125315 Russia.

S G Morozov (SG)

Institute of General Pathology and Pathophysiology, Moscow, 125315 Russia.

E A Lysikova (EA)

Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Moscow oblast, 142432 Russia.

O A Lytkina (OA)

Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Moscow oblast, 142432 Russia.

I V Koroleva (IV)

Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Moscow oblast, 142432 Russia.

N Ia Popova (NI)

Pirogov Russian National Research Medical University, Moscow, 117997 Russia.

A I Antohin (AI)

Pirogov Russian National Research Medical University, Moscow, 117997 Russia.

R K Ovchinnikov (RK)

Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Moscow oblast, 142432 Russia.
Pirogov Russian National Research Medical University, Moscow, 117997 Russia.

M S Kukharsky (MS)

Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka, Moscow oblast, 142432 Russia.
Pirogov Russian National Research Medical University, Moscow, 117997 Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH